Irvine-based Cardiac Science Inc. said Tuesday that regulators approved its proposed combination with Quinton Cardiology Systems Inc.
Cardiac and Bothell, Wash.-based Quinton agreed to combine in late February, under the Cardiac Science name.
Quinton shareholders are set to get about three-quarters of a share in the new company for each share of Quinton stock. Cardiac shareholders are about to get a tenth of a share in the new Cardiac Science for every share of the old Cardiac stock.
The companies didn’t say when they expect the deal to close after getting approval from the Federal Trade Commission and Department of Justice.
On Monday, Cardiac, which makes heart defibrillators, said it expanded a distribution deal with General Electric Co.’s GE Healthcare unit.
The deal calls for GE Healthcare to market Cardiac’s Powerheart automated external defibrillators on an “exclusive basis” to hospitals in the U.S. and Canada.
